Dexamethasone soduim phosphate (DrugBank: Dexamethasone, Phosphate)
25 diseasesID | Disease name (Link within this page) | Number of trials |
---|---|---|
13 | Multiple sclerosis/Neuromyelitis optica | 1 |
14 | Chronic inflammatory demyelinating polyneuropathy | 0 |
16 | Crow-Fukase syndrome | 0 |
28 | Systemic amyloidosis | 0 |
35 | Pemphigus | 0 |
46 | Malignant rheumatoid arthritis | 0 |
53 | Sjogren syndrome | 0 |
63 | Idiopathic thrombocytopenic purpura | 0 |
64 | Thrombotic thrombocytopenic purpura | 0 |
65 | Primary immunodeficiency | 0 |
70 | Spinal stenosis | 0 |
74 | Prolactin secreting pituitary adenoma | 0 |
75 | Cushing disease | 0 |
81 | Congenital adrenal hyperplasia | 0 |
83 | Addison disease | 0 |
84 | Sarcoidosis | 0 |
90 | Retinitis pigmentosa | 0 |
96 | Crohn disease | 0 |
97 | Ulcerative colitis | 0 |
162 | Pemphigoid | 0 |
222 | Primary nephrotic syndrome | 0 |
235 | Hypoparathyroidism | 0 |
283 | Acquired pure red cell aplasia | 0 |
296 | Biliary atresia | 0 |
299 | Cystic fibrosis | 0 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT00674141 (ClinicalTrials.gov) | July 2008 | 6/5/2008 | Nasal Administration of Dexamethasone for Multiple Sclerosis (MS) Treatment | Nasal Administration of Dexamethasone for MS Treatment | MS Patient With Relpasing Remitting Attacks | Drug: Dexamethasone soduim phosphate | Hadassah Medical Organization | NULL | Withdrawn | 18 Years | N/A | Both | 10 | Phase 1 | Israel |